Officials from the Biden Administration met with drugmakers this week to discuss prices of naloxone, a drug used to immediately reverse opioid overdoses. Emergent Biosolutions, the manufacturer of brand name Narcan, took heat for setting its price for 2 doses at $50. Concerns were also raised about the high cost of other formulations, which can reach $100 for uninsured people.
According to David Ovalle, “While applauding the White House’s efforts, experts cautioned that the summit would not lead drug manufacturers to dramatically lower prices, especially when so many other factors affect prices, including the costs of manufacturing nasal sprays and health insurance coverage.”
To read more, click here.
(Source: The Washington Post, June 20th, 2023)